KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Moderna (MRNA) Other Gross PP&E Adjustments: 2017-2025

Historic Other Gross PP&E Adjustments for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to $2.1 billion.

  • Moderna's Other Gross PP&E Adjustments fell 4.14% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 billion, marking a year-over-year increase of 6.73%. This contributed to the annual value of $1.8 billion for FY2024, which is 17.95% up from last year.
  • As of Q3 2025, Moderna's Other Gross PP&E Adjustments stood at $2.1 billion, which was up 0.83% from $2.0 billion recorded in Q2 2025.
  • Moderna's Other Gross PP&E Adjustments' 5-year high stood at $2.3 billion during Q3 2023, with a 5-year trough of $408.0 million in Q1 2021.
  • Over the past 3 years, Moderna's median Other Gross PP&E Adjustments value was $2.0 billion (recorded in 2025), while the average stood at $1.9 billion.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 200.68% in 2021, then declined by 5.17% in 2024.
  • Over the past 5 years, Moderna's Other Gross PP&E Adjustments (Quarterly) stood at $884.0 million in 2021, then surged by 64.93% to $1.5 billion in 2022, then grew by 6.58% to $1.6 billion in 2023, then grew by 17.95% to $1.8 billion in 2024, then decreased by 4.14% to $2.1 billion in 2025.
  • Its Other Gross PP&E Adjustments was $2.1 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $2.0 billion in Q1 2025.